Friday, August 22, 2014 8:28:52 AM
NOTE 9 – SUBSEQUENT EVENTS
In accordance with ASC 855 the Company’s management reviewed all material events through the date of this report. The
Company has continued the financing process and from July 01 to August 07 a further conversion of 103,608,456 Common
Stock has been issued from converting Convertible Loan Notes.
The Company issued 326,535,956 shares of common stock in return for redeeming Convertible Loan notes to the value of
$58,420 on April 01,14, 18, 22 and 24, May 06, 07, 08, 09, 19, 21, 23 and 28 and June 03, 09, 10, 12, 18, 25 and 26, 2014.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM